What RESMED INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 4 | 28 |
| Total trades | 18 | 70 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 70 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. | Chairman and CEO | Nov 11 | Withheld — tax / exercise cost · F | −2,436 | $234.11 | −$570K | 471,774 |
| Farrell Michael J. | Chairman and CEO | Nov 11 | Withheld — tax / exercise cost · F | −2,210 | $234.11 | −$517K | 474,209 |
| Farrell Michael J. | Chairman and CEO | Nov 11 | Withheld — tax / exercise cost · F | −3,466 | $234.11 | −$811K | 476,419 |
| Bloomer Aaron | Chief Financial Officer | Nov 11 | Withheld — tax / exercise cost · F | −1,095 | $234.11 | −$256K | 7,977 |
| Farrell Peter C | Director | Nov 11 | Withheld — tax / exercise cost · F | −169 | $234.11 | −$39.6K | 51,634 |
| De Witte Jan | Director | Nov 11 | Withheld — tax / exercise cost · F | −60 | $234.11 | −$14K | 4,201 |
| Gill Harjit | Director | Nov 11 | Withheld — tax / exercise cost · F | −36 | $234.11 | −$8.36K | 10,904 |
| Rider Michael J | Global General Counsel | Nov 11 | Withheld — tax / exercise cost · F | −173 | $234.11 | −$40.5K | 10,417 |
| Rider Michael J | Global General Counsel | Nov 11 | Withheld — tax / exercise cost · F | −724 | $234.11 | −$170K | 10,590 |
| Rider Michael J | Global General Counsel | Nov 11 | Withheld — tax / exercise cost · F | −499 | $234.11 | −$117K | 11,314 |
| Rider Michael J | Global General Counsel | Nov 11 | Withheld — tax / exercise cost · F | −547 | $234.11 | −$128K | 11,813 |
| Farrell Michael J. | Chairman and CEO | Nov 09 | Open-market sale · S | −4,993 | $235.35 | −$1.18M | 479,803 |
| Farrell Michael J. | Chairman and CEO | Nov 09 | Exercise / conversion · M | +4,310 | $146.34 | +$631K | 484,796 |
| Farrell Michael J. | Chairman and CEO | Nov 09 | Exercise / conversion · M | +683 | $146.34 | +$100K | 480,486 |
| Rider Michael J | Global General Counsel | Oct 23 | Open-market sale · S | −400 | $255.00 | −$102K | 12,318 |
| Farrell Michael J. | Chairman and CEO | Oct 07 | Open-market sale · S | −4,991 | $226.33 | −$1.13M | 479,803 |
| Farrell Michael J. | Chairman and CEO | Oct 07 | Exercise / conversion · M | +4,991 | $146.34 | +$730K | 484,794 |
| Farrell Peter C | Director | Sep 02 | Open-market sale · S | −970 | $234.73 | −$228K | 51,803 |
| Bloomer Aaron | Chief Financial Officer | Aug 14 | Grant / award · A | +9,072 | — | — | 9,072 |
| Leong Justin | Chief Product Officer | Aug 14 | Grant / award · A | +6,461 | — | — | 35,489 |
Loading...